Edward Van Wezel
Board of Directors
Business & Management
Synaffix
Netherlands
Biography
Edward is managing partner and founder of BioGeneration Ventures. He has extensive international expertise in small and large pharma and biotech companies and currently serves on the boards of NovioGendix, Progentix Orthobiology, Cristal Therapeutics and Acerta Pharma as well as BioCeros until it was sold in 2011. Edward started his industrial career as process engineer for Chiron Inc. and working for Johnson & Johnson as project manager, where was responsible for preclinical and Phase II oncology development projects and was involved in in-licensing activities. Since 2000, he gained experience in several small start-up and early stage companies in the Netherlands. He was director of business development at Pepscan Systems and managing director of Macrozyme, until the formation of a successful partnership with Genzyme Inc. in 2005. Edward holds a MSc in chemistry from the University of Utrecht and a MSc in biochemical engineering from the Delft University of Technology.
Research Interest
Business & Management
